Literature DB >> 15000463

Amlodipine besylate-excipients interaction in solid dosage form.

A Abdoh1, M M Al-Omari, A A Badwan, A M Y Jaber.   

Abstract

This article studies the compatibility of amlodipine besylate in its solid formulations with various drug excipients. The various factors affecting amlodipine besylate stability were studied using high-performance liquid chromatography (HPLC). It has been found that binary 1:1 mixtures of amlodipine besylate and an excipient are stable at 65 degrees C and 40 degrees C/75% RH. Further investigations were conducted to study the stability of amlodipine besylate in multicomponent mixtures, including mixtures with actual formulations. The study reveals that mixtures of lactose, magnesium stearate, and water induce some instability on amlodipine besylate. The major degradation product confirmed by HPLC-mass spectrometry is amlodipine besylate glycosyl. This is in conformity with the well-known Maillard reaction between primary amines and lactose. Thus, lactose-free amlodipine formulations are recommended from the safety, quality, efficacy, and process cost points of view.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000463     DOI: 10.1081/pdt-120027414

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  5 in total

Review 1.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

2.  Assessment of feasibility of maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies.

Authors:  Farnaz Monajjemzadeh; Davoud Hassanzadeh; Hadi Valizadeh; Mohammad R Siahi-Shadbad; Javid Shahbazi Mojarrad; Thomas Robertson; Michael S Roberts
Journal:  AAPS PharmSciTech       Date:  2009-05-20       Impact factor: 3.246

3.  Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.

Authors:  Nidal Daraghmeh; Iyad Rashid; Mahmoud M H Al Omari; Stephen A Leharne; Babur Z Chowdhry; Adnan Badwan
Journal:  AAPS PharmSciTech       Date:  2010-11-04       Impact factor: 3.246

4.  Post hoc study to investigate the potential causes of poor quality of cardiovascular medicines collected in sub-Saharan countries.

Authors:  Philippe-Henri Secretan; Marie Antignac; Najet Yagoubi; Mélisande Bernard; Marie Cécile Perier; Jean Laurent Takombe; Dadhi Balde; Roland N'Guetta; Méo Stéphane Ikama; Patrice Zabsonre; Abdallahi Sidi Aly; Xavier Jouven; Bernard Do
Journal:  BMJ Open       Date:  2020-11-09       Impact factor: 2.692

5.  Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.

Authors:  Ummarah Kanwal; Shahid Mukhtar; Muzzamil Waheed; Arifa Mehreen; Nasir Abbas; Rahat Shamim; Khalid Hussain; Fatima Rasool; Amjad Hussain; Nadeem Irfan Bukhari
Journal:  Drug Des Devel Ther       Date:  2021-05-24       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.